Community/Retail

There are many misconceptions surrounding pain management, especially when it comes to opioids with abuse-deterrent properties.

J. David Haddox, DDS, MD, describes how clinicians can determine whether an opioid has abuse-deterrent properties.

J. David Haddox, DDS, MD, describes the pharmacist's role in deterring opioid abuse.

The answer may surprise you.

J. David Haddox, DDS, MD, describes the most common method of opioid abuse.

J. David Haddox, DDS, MD, corrects a misconception about opioids with abuse-deterrent properties.

J. David Haddox, DDS, MD, explains how most nonmedical opioid users obtain the drug.

Does the prospect of continuing lower reimbursement rates, crazy hours, longer phone wait times, and slow and inefficient pharmacy software have you considering a new career?

Erin L. Albert, MBA, PharmD, JD, is the interviewee, with the tables turned with special guest podcast host Lauren Steinbach.

Pharmacists are much more likely to see prescriptions for sodium-glucose co-transporter 2 (SGLT2) inhibitors than obesity medications, recent prescription data reveal.

Sagent Pharmaceuticals is recalling one lot of injectable oxacillin because a single vial contained dark particulate matter identified as iron oxide.

A rookie state police trooper recently testified against a gun-wielding man he prevented from robbing a Walmart pharmacy of fentanyl.

In recognition of National Family Meals Month, Hy-Vee will donate up to $100,000 to Meals from the Heartland when families post a photo of themselves eating together on social media.

Gilead Sciences maker of hepatitis C virus blockbusters Sovaldi, Harvoni, and, most recently, Epclusa has come under increasing scrutiny for declining revenues, both in the near-term and beyond.

As the prevalence of pneumonia affects a variety of patient populations, it's imperative for health care professionals to stay current on changing guidelines.

The allegations seem foggy.

Professional development is a huge part of pharmacy, and attending conferences is a huge part of professional development.

The discovery of otulipenia suggests a strong link between ubiquitin and inflammation.

The top 200 drugs list changes every year. Here's a way to keep up and help your classmates.

Learn about the new products and expanded indications approved by the FDA in August 2016.

Two nationally recognized managed care pharmacy experts have been appointed to influential advisory panels of the Patient-Centered Outcomes Research Institute (PCORI) based on joint nominations by the Academy of Managed Care Pharmacy (AMCP) and AMCP Foundation.

The Generic Pharmaceutical Associations (GPhA) shares Secretary Clinton's desire to make medicines affordable and accessible.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Routine vaccination declines significantly as patients enter adolescence.

Interventions to improve medication adherence tend to focus on short-term nonadherence and ignore sustained social issues.

Sanofi has submitted updated information to the FDA as part of a previously submitted New Drug Application (NDA) for its investigational once-daily, fixed-ratio combination of basal insulin glargine 100 units/mL (Lantus) and lixisenatide (Adlyxin) to treat type 2 diabetes in adults.

The FDA is adding its strongest possible warnings to the drug labeling of prescription opioid pain medications, opioid cough medicines, and benzodiazepines concerning serious adverse effects seen with concomitant use.

The latest investigation by the Medicare Fraud Strike Force has resulted in charges against 8 Florida residents for counts of conspiracy to commit health care fraud, wire fraud, and money laundering, according to the Department of Justice (DOJ).

The FDA has granted Fast Track designation to Lilly and AstraZeneca's investigational treatment for Alzheimer's disease.

Pharmacists and pharmaceutical scientists must take responsibility for mitigating the environmental consequences of medicines, the International Pharmaceutical Federation (FIP) says.